Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Indian Parliamentary Committee Lashes Out At Pricing Watchdog NPPA

This article was originally published in PharmAsia News

Executive Summary

NEW DELHI - Concerned by the slugglish performance of the pricing of medicines - in recovering funds from defaulting drug makers, the Parliamentary Standing Committee on chemicals and fertilizers has asked the National Pharmaceuticals Pricing Authority to bring the process up to speed

You may also be interested in...



A Long Way Still For Corrupt Business Practices In China, India - Pharmaceutical Regulatory And Compliance Congress

SINGAPORE - Major Chinese pharma companies are eyeing acquisitions of companies in lucrative Western markets to establish a global foothold, according to industry observers

A Long Way Still For Corrupt Business Practices In China, India - Pharmaceutical Regulatory And Compliance Congress

SINGAPORE - Major Chinese pharma companies are eyeing acquisitions of companies in lucrative Western markets to establish a global foothold, according to industry observers

Indian Pricing Watchdog NPPA Turns Down Requests For Insulin Price Hike; Lilly Moves To Court

MUMBAI - Several global pharmaceutical firms are heading for a collision with India's National Pharmaceutical Pricing Authority after the drug price regulator turned down their requests for an upward price revision of leading imported brands

UsernamePublicRestriction

Register

SC143162

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel